Average Co-Inventor Count = 1.54
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (11 from 410 patents)
2. Tufts Medical Center, Inc. (2 from 77 patents)
11 patents:
1. 12286474 - Anti-CD38 antibodies for treatment of acute myeloid leukemia
2. 12091466 - Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
3. 12060432 - Combination therapies with anti-CD38 antibodies
4. 11713355 - Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
5. 10800851 - Combination therapies with anti-CD38 antibodies
6. 10793630 - Anti-CD38 antibodies for treatment of acute myeloid leukemia
7. 10766965 - Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
8. 10668149 - Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors
9. 10556961 - Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
10. 9732154 - Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
11. 9603927 - Combination therapies with anti-CD38 antibodies